← All Sponsors
SPONSOR

Milestone Pharmaceuticals Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Paroxysmal Supraventricular Tachycardia
NCT05763953 Phase 2
Recruiting

The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)

Paroxysmal Supraventricular Tachycardia
United States, Canada, Germany View Trial →